BSCL2 and congenital generalized lipodystrophy type 2: We therefore speculate that gene therapy is unlikely to have restored significant quantities of bone marrow adipose tissue, which has been shown to be severely depleted in adipose-tissue-specific Bscl2 KO mice and patients with CGL2.5